Title: I move to amend House Bill No. 2584 as follows:
Official Title: I move to amend House Bill No. 2584 as follows:
Number of Sections: 7
Source: versions - Committee Amendment 1
Media Type: application/pdf
Strikethrough Detection: 14 sections found

================================================================================

Section 1:
SENATE CHAMBER
STATE OF OKLAHOMA DISPOSITION
FLOOR AMENDMENT No. ________
COMMITTEE AMENDMENT
(Date)

Section 2:
1. On Page 2, Line 1 ½, by inserting the attached new Section 1 and renumbering subsequent

Section 3:
sections;

Section 4:
2. On Page 8, Line 18, by deleting after the word “shall”, all language;

Section 5:
3. On Page 13, Line 15 ½, by inserting the following new subsection H:
“H. 1. A physician assistant, or the employer of the physician assistant on his or her behalf,
shall carry malpractice insurance or demonstrate proof of financial responsibility in a minimum
amount of One Million Dollars ($1,000,000.00) per occurrence and Three Million Dollars
($3,000,000.00) in the aggregate per year. This requirement shall apply only to the physician
assistant and shall not be construed as to require the physician assistant to provide malpractice
insurance coverage to any delegating physician.

Section 6:
2. A physician assistant who is employed by or under contract with a federal agency that
carries malpractice insurance in any amount on behalf of the physician assistant shall be deemed in
compliance with paragraph 1 of this subsection when practicing under such federal employment or
contract. However, to the extent the physician assistant practices outside of such federal
employment or contract, the physician assistant, or his or her employer, shall comply with paragraph
1 of this subsection.”; and

Section 7:
3. By amending the title to conform.
Submitted by:
_______________________
Senator Rosino
Rosino-DC-CA-HB2584
4/21/2025 2:10 PM
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 SECTION 1. AMENDATORY 59 O.S. 2021, Section 353.1, as
2 amended by Section 6, Chapter 288, O.S.L. 2022 (59 O.S. Supp. 2024,
3 Section 353.1), is amended to read as follows:
4 Section 353.1. For the purposes of the Oklahoma Pharmacy Act:
5 1. “Accredited program” means those seminars, classes,
6 meetings, work projects, and other educational courses approved by
7 the Board State Board of Pharmacy for purposes of continuing
8 professional education;
9 2. “Act” means the Oklahoma Pharmacy Act;
10 3. “Administer” means the direct application of a drug,
11 whether by injection, inhalation, ingestion, or any other means, to
12 the body of a patient;
13 4. “Assistant pharmacist” means any person presently licensed
14 as an assistant pharmacist in the State of Oklahoma this state by
15 the Board pursuant to Section 353.10 of this title and for the
16 purposes of the Oklahoma Pharmacy Act shall be considered the same
17 as a pharmacist, except where otherwise specified;
18 5. “Board” or “State Board” means the State Board of Pharmacy;
19 6. “Certify” or “certification of a prescription” means the
20 review of a filled prescription by a licensed pharmacist or a
21 licensed practitioner with dispensing authority to confirm that the
22 medication, labeling, and packaging of the filled prescription are
23 accurate and meet all requirements prescribed by state and federal
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 law. For the purposes of this paragraph, “licensed practitioner”
2 shall not include optometrists with dispensing authority;
3 7. “Chemical” means any medicinal substance, whether simple or
4 compound or obtained through the process of the science and art of
5 chemistry, whether of organic or inorganic origin;
6 8. “Compounding” means the combining, admixing, mixing,
7 diluting, pooling, reconstituting, or otherwise altering of a drug
8 or bulk drug substance to create a drug. Compounding includes the
9 preparation of drugs or devices in anticipation of prescription
10 drug orders based on routine, regularly observed prescribing
11 patterns;
12 9. “Continuing professional education” means professional,
13 pharmaceutical education in the general areas of the socioeconomic
14 and legal aspects of health care; the properties and actions of
15 drugs and dosage forms; and the etiology, characteristics, and
16 therapeutics of the diseased state;
17 10. “Dangerous drug”, “legend drug”, “prescription drug”, or
18 “Rx Only” means a drug:
19 a. for human use subject to 21 U.S.C., Section
20 353(b)(1), or
21 b. is labeled “Prescription Only”, or labeled with the
22 following statement: “Caution: Federal law
23 restricts this drug except for to use by or on the
24 order of a licensed veterinarian.”;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 11. “Director” means the Executive Director of the State Board
2 of Pharmacy unless context clearly indicates otherwise;
3 12. “Dispense” or “dispensing” means the interpretation,
4 evaluation, and implementation of a prescription drug order
5 including the preparation and delivery of a drug or device to a
6 patient or a patient’s agent in a suitable container appropriately
7 labeled for subsequent administration to, or use by, a patient.
8 Dispense includes sell, distribute, leave with, give away, dispose
9 of, deliver, or supply;
10 13. “Dispenser” means a retail pharmacy, hospital pharmacy, a
11 group of chain pharmacies under common ownership and control that
12 do not act as a wholesale distributor, or any other person
13 authorized by law to dispense or administer prescription drugs, and
14 the affiliated warehouses or distributions of such entities under
15 common ownership and control that do not act as a wholesale
16 distributor. For the purposes of this paragraph, “dispenser”
17 dispenser does not mean a person who dispenses only products to be
18 used in animals in accordance with 21 U.S.C., Section 360b(a)(5);
19 14. “Distribute” or “distribution” means the sale, purchase,
20 trade, delivery, handling, storage, or receipt of a product, and
21 does not include the dispensing of a product pursuant to a
22 prescription executed in accordance with 21 U.S.C., Section
23 353(b)(1) or the dispensing of a product approved under 21 U.S.C.,
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 Section 360b(b); provided, taking actual physical possession of a
2 product or title shall not be required;
3 15. “Doctor of Pharmacy” means a person licensed by the Board
4 to engage in the practice of pharmacy. The terms “pharmacist”,
5 “D.Ph.”, and “Doctor of Pharmacy” shall be interchangeable and
6 shall have the same meaning wherever they appear in the Oklahoma
7 Statutes and the rules promulgated by the Board;
8 16. “Drug outlet” means all manufacturers, repackagers,
9 outsourcing facilities, wholesale distributors, third-party
10 logistics providers, pharmacies, and all other facilities which are
11 engaged in dispensing, delivery, distribution, or storage of
12 dangerous drugs;
13 17. “Drugs” means all medicinal substances and preparations
14 recognized by the United States Pharmacopoeia Pharmacopeia and
15 National Formulary, or any revision thereof, and all substances and
16 preparations intended for external and/or internal use in the cure,
17 diagnosis, mitigation, treatment, or prevention of disease in
18 humans or animals and all substances and preparations, other than
19 food, intended to affect the structure or any function of the body
20 of a human or animals;
21 18. “Drug sample” means a unit of a prescription drug packaged
22 under the authority and responsibility of the manufacturer that is
23 not intended to be sold and is intended to promote the sale of the
24 drug;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 19. “Durable medical equipment” has the same meaning as
2 provided by Section 2 of this act Section 375.2 of this title;
3 20. “Filled prescription” means a packaged prescription
4 medication to which a label has been affixed which contains such
5 information as is required by the Oklahoma Pharmacy Act;
6 21. “Hospital” means any institution licensed as a hospital by
7 this state for the care and treatment of patients, or a pharmacy
8 operated by the Oklahoma Department of Veterans Affairs;
9 22. “Licensed practitioner” means:
10 a. an allopathic physician,
11 b. an osteopathic physician,
12 c. a podiatric physician,
13 d. a dentist,
14 e. a veterinarian or,
15 f. an optometrist, or
16 g. a physician assistant,
17 licensed to practice and authorized to prescribe dangerous drugs
18 within the scope of practice of such practitioner;
19 23. “Manufacturer” or “virtual manufacturer” means with
20 respect to a product:
21 a. a person that holds an application approved under 21
22 U.S.C., Section 355 or a license issued under 42
23 U.S.C., Section 262 for such product, or if such
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 product is not the subject of an approved application
2 or license, the person who manufactured the product,
3 b. a co-licensed partner of the person described in
4 subparagraph a of this paragraph that obtains the
5 product directly from a person described in this
6 subparagraph or subparagraph a of this paragraph,
7 c. an affiliate of a person described in subparagraph a
8 or b of this paragraph who receives the product
9 directly from a person described in this subparagraph
10 or in subparagraph a or b of this paragraph, or
11 d. a person who contracts with another to manufacture a
12 product;
13 24. “Manufacturing” means the production, preparation,
14 propagation, compounding, conversion, or processing of a device or
15 a drug, either directly or indirectly by extraction from substances
16 of natural origin or independently by means of chemical or
17 biological synthesis and includes any packaging or repackaging of
18 the substances or labeling or relabeling of its container, and the
19 promotion and marketing of such drugs or devices. The term
20 “manufacturing” manufacturing also includes the preparation and
21 promotion of commercially available products from bulk compounds
22 for resale by licensed pharmacies, licensed practitioners, or other
23 persons;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 25. “Medical gas” means those gases including those in liquid
2 state upon which the manufacturer or distributor has placed one of
3 several cautions, such as “Rx Only”, in compliance with federal
4 law;
5 26. “Medical gas order” means an order for medical gas issued
6 by a licensed prescriber;
7 27. “Medical gas distributor” means a person licensed to
8 distribute, transfer, wholesale, deliver, or sell medical gases on
9 drug orders to suppliers or other entities licensed to use,
10 administer, or distribute medical gas and may also include a
11 patient or ultimate user;
12 28. “Medical gas supplier” means a person who dispenses
13 medical gases on drug orders only to a patient or ultimate user;
14 29. “Medicine” means any drug or combination of drugs which
15 has the property of curing, preventing, treating, diagnosing, or
16 mitigating diseases, or which is used for that purpose;
17 30. “Nonprescription drugs” means medicines or drugs which are
18 sold without a prescription and which are prepackaged for use by
19 the consumer and labeled in accordance with the requirements of the
20 statutes and regulations of this state and the federal government.
21 Such items shall also include medical and dental supplies and
22 bottled or nonbulk chemicals which are sold or offered for sale to
23 the general public if such articles or preparations meet the
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 requirements of the Federal Food, Drug, and Cosmetic Act, 21
2 U.S.C.A., Section 321 et seq.;
3 31. “Outsourcing facility” including “virtual outsourcing
4 facility” means a facility at one geographic location or address
5 that:
6 a. is engaged in the compounding of sterile drugs,
7 b. has elected to register as an outsourcing facility,
8 and
9 c. complies with all requirements of 21 U.S.C., Section
10 353b;
11 32. “Package” means the smallest individual saleable unit of
12 product for distribution by a manufacturer or repackager that is
13 intended by the manufacturer for ultimate sale to the dispenser of
14 such product. For the purposes of this paragraph, “individual
15 saleable unit” means the smallest container of a product introduced
16 into commerce by the manufacturer or repackager that is intended by
17 the manufacturer or repackager for individual sale to a dispenser;
18 33. “Person” means an individual, partnership, limited
19 liability company, corporation, or association, unless the context
20 otherwise requires;
21 34. “Pharmacist-in-charge” or “PIC” means the pharmacist
22 licensed in this state responsible for the management control of a
23 pharmacy and all other aspects of the practice of pharmacy in a
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 licensed pharmacy as defined provided by Section 353.18 of this
2 title;
3 35. “Pharmacy” means a place regularly licensed by the State
4 Board of Pharmacy in which prescriptions, drugs, medicines,
5 chemicals, and poisons are compounded or dispensed or such place
6 where pharmacists practice the profession of pharmacy, or a
7 pharmacy operated by the Oklahoma Department of Veterans Affairs;
8 36. “Pharmacy technician”, “technician”, “Rx tech”, or “tech”
9 means a person issued a Technician technician permit by the State
10 Board of Pharmacy to assist the pharmacist and perform
11 nonjudgmental, technical, manipulative, non-discretionary functions
12 in the prescription department under the immediate and direct
13 supervision of a pharmacist;
14 37. “Poison” means any substance which when introduced into
15 the body, either directly or by absorption, produces violent,
16 morbid, or fatal changes, or which destroys living tissue with
17 which such substance comes into contact;
18 38. “Practice of pharmacy” means:
19 a. the interpretation and evaluation of prescription
20 orders,
21 b. the compounding, dispensing, administering, and
22 labeling of drugs and devices, except labeling by a
23 manufacturer, repackager, or distributor of
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 nonprescription drugs and commercially packaged
2 legend drugs and devices,
3 c. the participation in drug selection and drug
4 utilization reviews,
5 d. the proper and safe storage of drugs and devices and
6 the maintenance of proper records thereof,
7 e. the responsibility for advising by counseling and
8 providing information, where professionally necessary
9 or where regulated, of therapeutic values, content,
10 hazards, and use of drugs and devices,
11 f. the offering or performing of those acts, services,
12 operations, or transactions necessary in the conduct,
13 operation, management, and control of a pharmacy, or
14 g. the provision of those acts or services that are
15 necessary to provide pharmaceutical care;
16 39. “Preparation” means an article which may or may not
17 contain sterile products compounded in a licensed pharmacy pursuant
18 to the order of a licensed prescriber;
19 40. “Prescriber” means a person licensed in this state who is
20 authorized to prescribe dangerous drugs within the scope of
21 practice of the person’s profession;
22 41. “Prescription” means and includes any order for drug or
23 medical supplies written or signed, or transmitted by word of
24 mouth, telephone, or other means of communication:
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 a. by a licensed prescriber,
2 b. (1) under the supervision of an Oklahoma licensed
3 practitioner a supervising physician, by an Oklahoma
4 licensed advanced practice registered nurse, or
5 (2) by an Oklahoma licensed physician assistant
6 pursuant to a practice agreement, or
7 c. by an Oklahoma licensed wholesaler or distributor as
8 authorized in Section 353.29.1 of this title;
9 42. “Product” means a prescription drug in a finished dosage
10 form for administration to a patient without substantial further
11 manufacturing, such as capsules, tablets, and lyophilized products
12 before reconstitution. “Product” Product does not include blood
13 components intended for transfusion, radioactive drugs or biologics
14 and medical gas;
15 43. “Repackager”, including “virtual repackager”, means a
16 person who owns or operates an establishment that repacks and
17 relabels a product or package for further sale or distribution
18 without further transaction;
19 44. “Sterile drug” means a drug that is intended for
20 parenteral administration, an ophthalmic or oral inhalation drug in
21 aqueous format, or a drug that is required to be sterile under
22 state and federal law;
23 45. “Supervising physician” means an individual holding a
24 current license to practice as a physician from the State Board of
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 Medical Licensure and Supervision, pursuant to the provisions of
2 the Oklahoma Allopathic Medical and Surgical Licensure and
3 Supervision Act, or the State Board of Osteopathic Examiners,
4 pursuant to the provisions of the Oklahoma Osteopathic Medicine
5 Act, who supervises an advanced practice registered nurse as
6 defined in Section 567.3a of this title,
7 and who is not in training as an intern, resident, or fellow. To
8 be eligible to supervise an advanced practice registered nurse,
9 such physician shall remain in compliance with the rules
10 promulgated by the State Board of Medical Licensure and Supervision
11 or the State Board of Osteopathic Examiners;
12 46. “Supportive personnel” means technicians and auxiliary
13 supportive persons who are regularly paid employees of a pharmacy
14 who work and perform tasks in the pharmacy as authorized by Section
15 353.18A of this title;
16 47. “Third-party logistics provider” including “virtual third-
17 party logistics provider” means an entity that provides or
18 coordinates warehousing, or other logistics services of a product
19 in interstate commerce on behalf of a manufacturer, wholesale
20 distributor, or dispenser of a product but does not take ownership
21 of the product, nor have responsibility to direct the sale or
22 disposition of the product. For the purposes of this paragraph,
23 “third-party logistics provider” third-party logistics provider
24 does not include shippers and the United States Postal Service;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
1 48. “Wholesale distributor” including “virtual wholesale
2 distributor” means a person other than a manufacturer, a
3 manufacturer’s co-licensed partner, a third-party logistics
4 provider, or repackager engaged in wholesale distribution as
5 defined by 21 U.S.C., Section 353(e)(4) as amended by the Drug
6 Supply Chain Security Act;
7 49. “County jail” means a facility operated by a county for
8 the physical detention and correction of persons charged with, or
9 convicted of, criminal offenses or ordinance violations or persons
10 found guilty of civil or criminal contempt;
11 50. “State correctional facility” means a facility or
12 institution that houses a prisoner population under the
13 jurisdiction of the Department of Corrections;
14 51. “Unit dose package” means a package that contains a single
15 dose drug with the name, strength, control number, and expiration
16 date of that drug on the label; and
17 52. “Unit of issue package” means a package that provides
18 multiple doses of the same drug, but each drug is individually
19 separated and includes the name, lot number, and expiration date.
20
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment
[DELETED:  D        A  SS D N      S_S]
[DELETED:  D        A  S S a S S 1 m t p 2 3 w t 4 a t p a 5 6 r l m a]
[DELETED:  D        A  S l s 7 c c 8 d o p d p 9 p a d t 1 “ a f 3 b i f r o]
[DELETED:  D        A  S 1 o 1 e i p l D o 1 g d a t c d d u 1 t d p 3]
[DELETED:  D        A  S S p 1 t “ s S 1 o l e d 1 r N p d h f o 1 u n d]
[DELETED:  D        A  S 1 p 2 m i 2 t o 2 a a b a c a d a e a f a g a l w 2 r a a U U]
[DELETED:  D        A  S p o b a s p s c a o d o d a p 2 p a o b t p “ p f p]
[DELETED:  D        A  S 2 s s l 2 b 2 d d a p 2 m 2 h m 3 s t s S b t]
[DELETED:  D        A  S r U 3 f t a i b h a c c 3 3 p i s s i t 3 l o 3 l p]
[DELETED:  D        A  S l t 3 B c w p 3 m B n i s 3 t m w 3 a t o b t l m]
[DELETED:  D        A  S n l c t u d t t e t p o h f t o o g t n 3 c t 4 a p 4 m m]
[DELETED:  D        A  S a b b ( u p l ( b p c b a 4 f m b c a 4 p r w 4 p a s 4 c]
[DELETED:  D        A  S M t S p A d a b s p o 4 s w 3 4 p c i d o d “ d]
[DELETED:  D        A  S 4 d m p d S 4 t c f 5 i j 5 d d 5 m s ]


================================================================================

Raw Text:
SENATE CHAMBER
STATE OF OKLAHOMA DISPOSITION
FLOOR AMENDMENT No. ________
COMMITTEE AMENDMENT
(Date)
I move to amend House Bill No. 2584 as follows:
1. On Page 2, Line 1 ½, by inserting the attached new Section 1 and renumbering subsequent
sections;
2. On Page 8, Line 18, by deleting after the word “shall”, all language;
3. On Page 13, Line 15 ½, by inserting the following new subsection H:
“H. 1. A physician assistant, or the employer of the physician assistant on his or her behalf,
shall carry malpractice insurance or demonstrate proof of financial responsibility in a minimum
amount of One Million Dollars ($1,000,000.00) per occurrence and Three Million Dollars
($3,000,000.00) in the aggregate per year. This requirement shall apply only to the physician
assistant and shall not be construed as to require the physician assistant to provide malpractice
insurance coverage to any delegating physician.
2. A physician assistant who is employed by or under contract with a federal agency that
carries malpractice insurance in any amount on behalf of the physician assistant shall be deemed in
compliance with paragraph 1 of this subsection when practicing under such federal employment or
contract. However, to the extent the physician assistant practices outside of such federal
employment or contract, the physician assistant, or his or her employer, shall comply with paragraph
1 of this subsection.”; and
3. By amending the title to conform.
Submitted by:
_______________________
Senator Rosino
Rosino-DC-CA-HB2584
4/21/2025 2:10 PM
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 SECTION 1. AMENDATORY 59 O.S. 2021, Section 353.1, as
2 amended by Section 6, Chapter 288, O.S.L. 2022 (59 O.S. Supp. 2024,
3 Section 353.1), is amended to read as follows:
4 Section 353.1. For the purposes of the Oklahoma Pharmacy Act:
5 1. “Accredited program” means those seminars, classes,
6 meetings, work projects, and other educational courses approved by
7 the Board State Board of Pharmacy for purposes of continuing
8 professional education;
9 2. “Act” means the Oklahoma Pharmacy Act;
10 3. “Administer” means the direct application of a drug,
11 whether by injection, inhalation, ingestion, or any other means, to
12 the body of a patient;
13 4. “Assistant pharmacist” means any person presently licensed
14 as an assistant pharmacist in the State of Oklahoma this state by
15 the Board pursuant to Section 353.10 of this title and for the
16 purposes of the Oklahoma Pharmacy Act shall be considered the same
17 as a pharmacist, except where otherwise specified;
18 5. “Board” or “State Board” means the State Board of Pharmacy;
19 6. “Certify” or “certification of a prescription” means the
20 review of a filled prescription by a licensed pharmacist or a
21 licensed practitioner with dispensing authority to confirm that the
22 medication, labeling, and packaging of the filled prescription are
23 accurate and meet all requirements prescribed by state and federal
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 law. For the purposes of this paragraph, “licensed practitioner”
2 shall not include optometrists with dispensing authority;
3 7. “Chemical” means any medicinal substance, whether simple or
4 compound or obtained through the process of the science and art of
5 chemistry, whether of organic or inorganic origin;
6 8. “Compounding” means the combining, admixing, mixing,
7 diluting, pooling, reconstituting, or otherwise altering of a drug
8 or bulk drug substance to create a drug. Compounding includes the
9 preparation of drugs or devices in anticipation of prescription
10 drug orders based on routine, regularly observed prescribing
11 patterns;
12 9. “Continuing professional education” means professional,
13 pharmaceutical education in the general areas of the socioeconomic
14 and legal aspects of health care; the properties and actions of
15 drugs and dosage forms; and the etiology, characteristics, and
16 therapeutics of the diseased state;
17 10. “Dangerous drug”, “legend drug”, “prescription drug”, or
18 “Rx Only” means a drug:
19 a. for human use subject to 21 U.S.C., Section
20 353(b)(1), or
21 b. is labeled “Prescription Only”, or labeled with the
22 following statement: “Caution: Federal law
23 restricts this drug except for to use by or on the
24 order of a licensed veterinarian.”;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 11. “Director” means the Executive Director of the State Board
2 of Pharmacy unless context clearly indicates otherwise;
3 12. “Dispense” or “dispensing” means the interpretation,
4 evaluation, and implementation of a prescription drug order
5 including the preparation and delivery of a drug or device to a
6 patient or a patient’s agent in a suitable container appropriately
7 labeled for subsequent administration to, or use by, a patient.
8 Dispense includes sell, distribute, leave with, give away, dispose
9 of, deliver, or supply;
10 13. “Dispenser” means a retail pharmacy, hospital pharmacy, a
11 group of chain pharmacies under common ownership and control that
12 do not act as a wholesale distributor, or any other person
13 authorized by law to dispense or administer prescription drugs, and
14 the affiliated warehouses or distributions of such entities under
15 common ownership and control that do not act as a wholesale
16 distributor. For the purposes of this paragraph, “dispenser”
17 dispenser does not mean a person who dispenses only products to be
18 used in animals in accordance with 21 U.S.C., Section 360b(a)(5);
19 14. “Distribute” or “distribution” means the sale, purchase,
20 trade, delivery, handling, storage, or receipt of a product, and
21 does not include the dispensing of a product pursuant to a
22 prescription executed in accordance with 21 U.S.C., Section
23 353(b)(1) or the dispensing of a product approved under 21 U.S.C.,
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 Section 360b(b); provided, taking actual physical possession of a
2 product or title shall not be required;
3 15. “Doctor of Pharmacy” means a person licensed by the Board
4 to engage in the practice of pharmacy. The terms “pharmacist”,
5 “D.Ph.”, and “Doctor of Pharmacy” shall be interchangeable and
6 shall have the same meaning wherever they appear in the Oklahoma
7 Statutes and the rules promulgated by the Board;
8 16. “Drug outlet” means all manufacturers, repackagers,
9 outsourcing facilities, wholesale distributors, third-party
10 logistics providers, pharmacies, and all other facilities which are
11 engaged in dispensing, delivery, distribution, or storage of
12 dangerous drugs;
13 17. “Drugs” means all medicinal substances and preparations
14 recognized by the United States Pharmacopoeia Pharmacopeia and
15 National Formulary, or any revision thereof, and all substances and
16 preparations intended for external and/or internal use in the cure,
17 diagnosis, mitigation, treatment, or prevention of disease in
18 humans or animals and all substances and preparations, other than
19 food, intended to affect the structure or any function of the body
20 of a human or animals;
21 18. “Drug sample” means a unit of a prescription drug packaged
22 under the authority and responsibility of the manufacturer that is
23 not intended to be sold and is intended to promote the sale of the
24 drug;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 19. “Durable medical equipment” has the same meaning as
2 provided by Section 2 of this act Section 375.2 of this title;
3 20. “Filled prescription” means a packaged prescription
4 medication to which a label has been affixed which contains such
5 information as is required by the Oklahoma Pharmacy Act;
6 21. “Hospital” means any institution licensed as a hospital by
7 this state for the care and treatment of patients, or a pharmacy
8 operated by the Oklahoma Department of Veterans Affairs;
9 22. “Licensed practitioner” means:
10 a. an allopathic physician,
11 b. an osteopathic physician,
12 c. a podiatric physician,
13 d. a dentist,
14 e. a veterinarian or,
15 f. an optometrist, or
16 g. a physician assistant,
17 licensed to practice and authorized to prescribe dangerous drugs
18 within the scope of practice of such practitioner;
19 23. “Manufacturer” or “virtual manufacturer” means with
20 respect to a product:
21 a. a person that holds an application approved under 21
22 U.S.C., Section 355 or a license issued under 42
23 U.S.C., Section 262 for such product, or if such
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 product is not the subject of an approved application
2 or license, the person who manufactured the product,
3 b. a co-licensed partner of the person described in
4 subparagraph a of this paragraph that obtains the
5 product directly from a person described in this
6 subparagraph or subparagraph a of this paragraph,
7 c. an affiliate of a person described in subparagraph a
8 or b of this paragraph who receives the product
9 directly from a person described in this subparagraph
10 or in subparagraph a or b of this paragraph, or
11 d. a person who contracts with another to manufacture a
12 product;
13 24. “Manufacturing” means the production, preparation,
14 propagation, compounding, conversion, or processing of a device or
15 a drug, either directly or indirectly by extraction from substances
16 of natural origin or independently by means of chemical or
17 biological synthesis and includes any packaging or repackaging of
18 the substances or labeling or relabeling of its container, and the
19 promotion and marketing of such drugs or devices. The term
20 “manufacturing” manufacturing also includes the preparation and
21 promotion of commercially available products from bulk compounds
22 for resale by licensed pharmacies, licensed practitioners, or other
23 persons;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 25. “Medical gas” means those gases including those in liquid
2 state upon which the manufacturer or distributor has placed one of
3 several cautions, such as “Rx Only”, in compliance with federal
4 law;
5 26. “Medical gas order” means an order for medical gas issued
6 by a licensed prescriber;
7 27. “Medical gas distributor” means a person licensed to
8 distribute, transfer, wholesale, deliver, or sell medical gases on
9 drug orders to suppliers or other entities licensed to use,
10 administer, or distribute medical gas and may also include a
11 patient or ultimate user;
12 28. “Medical gas supplier” means a person who dispenses
13 medical gases on drug orders only to a patient or ultimate user;
14 29. “Medicine” means any drug or combination of drugs which
15 has the property of curing, preventing, treating, diagnosing, or
16 mitigating diseases, or which is used for that purpose;
17 30. “Nonprescription drugs” means medicines or drugs which are
18 sold without a prescription and which are prepackaged for use by
19 the consumer and labeled in accordance with the requirements of the
20 statutes and regulations of this state and the federal government.
21 Such items shall also include medical and dental supplies and
22 bottled or nonbulk chemicals which are sold or offered for sale to
23 the general public if such articles or preparations meet the
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 requirements of the Federal Food, Drug, and Cosmetic Act, 21
2 U.S.C.A., Section 321 et seq.;
3 31. “Outsourcing facility” including “virtual outsourcing
4 facility” means a facility at one geographic location or address
5 that:
6 a. is engaged in the compounding of sterile drugs,
7 b. has elected to register as an outsourcing facility,
8 and
9 c. complies with all requirements of 21 U.S.C., Section
10 353b;
11 32. “Package” means the smallest individual saleable unit of
12 product for distribution by a manufacturer or repackager that is
13 intended by the manufacturer for ultimate sale to the dispenser of
14 such product. For the purposes of this paragraph, “individual
15 saleable unit” means the smallest container of a product introduced
16 into commerce by the manufacturer or repackager that is intended by
17 the manufacturer or repackager for individual sale to a dispenser;
18 33. “Person” means an individual, partnership, limited
19 liability company, corporation, or association, unless the context
20 otherwise requires;
21 34. “Pharmacist-in-charge” or “PIC” means the pharmacist
22 licensed in this state responsible for the management control of a
23 pharmacy and all other aspects of the practice of pharmacy in a
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 licensed pharmacy as defined provided by Section 353.18 of this
2 title;
3 35. “Pharmacy” means a place regularly licensed by the State
4 Board of Pharmacy in which prescriptions, drugs, medicines,
5 chemicals, and poisons are compounded or dispensed or such place
6 where pharmacists practice the profession of pharmacy, or a
7 pharmacy operated by the Oklahoma Department of Veterans Affairs;
8 36. “Pharmacy technician”, “technician”, “Rx tech”, or “tech”
9 means a person issued a Technician technician permit by the State
10 Board of Pharmacy to assist the pharmacist and perform
11 nonjudgmental, technical, manipulative, non-discretionary functions
12 in the prescription department under the immediate and direct
13 supervision of a pharmacist;
14 37. “Poison” means any substance which when introduced into
15 the body, either directly or by absorption, produces violent,
16 morbid, or fatal changes, or which destroys living tissue with
17 which such substance comes into contact;
18 38. “Practice of pharmacy” means:
19 a. the interpretation and evaluation of prescription
20 orders,
21 b. the compounding, dispensing, administering, and
22 labeling of drugs and devices, except labeling by a
23 manufacturer, repackager, or distributor of
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 nonprescription drugs and commercially packaged
2 legend drugs and devices,
3 c. the participation in drug selection and drug
4 utilization reviews,
5 d. the proper and safe storage of drugs and devices and
6 the maintenance of proper records thereof,
7 e. the responsibility for advising by counseling and
8 providing information, where professionally necessary
9 or where regulated, of therapeutic values, content,
10 hazards, and use of drugs and devices,
11 f. the offering or performing of those acts, services,
12 operations, or transactions necessary in the conduct,
13 operation, management, and control of a pharmacy, or
14 g. the provision of those acts or services that are
15 necessary to provide pharmaceutical care;
16 39. “Preparation” means an article which may or may not
17 contain sterile products compounded in a licensed pharmacy pursuant
18 to the order of a licensed prescriber;
19 40. “Prescriber” means a person licensed in this state who is
20 authorized to prescribe dangerous drugs within the scope of
21 practice of the person’s profession;
22 41. “Prescription” means and includes any order for drug or
23 medical supplies written or signed, or transmitted by word of
24 mouth, telephone, or other means of communication:
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 a. by a licensed prescriber,
2 b. (1) under the supervision of an Oklahoma licensed
3 practitioner a supervising physician, by an Oklahoma
4 licensed advanced practice registered nurse, or
5 (2) by an Oklahoma licensed physician assistant
6 pursuant to a practice agreement, or
7 c. by an Oklahoma licensed wholesaler or distributor as
8 authorized in Section 353.29.1 of this title;
9 42. “Product” means a prescription drug in a finished dosage
10 form for administration to a patient without substantial further
11 manufacturing, such as capsules, tablets, and lyophilized products
12 before reconstitution. “Product” Product does not include blood
13 components intended for transfusion, radioactive drugs or biologics
14 and medical gas;
15 43. “Repackager”, including “virtual repackager”, means a
16 person who owns or operates an establishment that repacks and
17 relabels a product or package for further sale or distribution
18 without further transaction;
19 44. “Sterile drug” means a drug that is intended for
20 parenteral administration, an ophthalmic or oral inhalation drug in
21 aqueous format, or a drug that is required to be sterile under
22 state and federal law;
23 45. “Supervising physician” means an individual holding a
24 current license to practice as a physician from the State Board of
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 Medical Licensure and Supervision, pursuant to the provisions of
2 the Oklahoma Allopathic Medical and Surgical Licensure and
3 Supervision Act, or the State Board of Osteopathic Examiners,
4 pursuant to the provisions of the Oklahoma Osteopathic Medicine
5 Act, who supervises an advanced practice registered nurse as
6 defined in Section 567.3a of this title,
7 and who is not in training as an intern, resident, or fellow. To
8 be eligible to supervise an advanced practice registered nurse,
9 such physician shall remain in compliance with the rules
10 promulgated by the State Board of Medical Licensure and Supervision
11 or the State Board of Osteopathic Examiners;
12 46. “Supportive personnel” means technicians and auxiliary
13 supportive persons who are regularly paid employees of a pharmacy
14 who work and perform tasks in the pharmacy as authorized by Section
15 353.18A of this title;
16 47. “Third-party logistics provider” including “virtual third-
17 party logistics provider” means an entity that provides or
18 coordinates warehousing, or other logistics services of a product
19 in interstate commerce on behalf of a manufacturer, wholesale
20 distributor, or dispenser of a product but does not take ownership
21 of the product, nor have responsibility to direct the sale or
22 disposition of the product. For the purposes of this paragraph,
23 “third-party logistics provider” third-party logistics provider
24 does not include shippers and the United States Postal Service;
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

1 48. “Wholesale distributor” including “virtual wholesale
2 distributor” means a person other than a manufacturer, a
3 manufacturer’s co-licensed partner, a third-party logistics
4 provider, or repackager engaged in wholesale distribution as
5 defined by 21 U.S.C., Section 353(e)(4) as amended by the Drug
6 Supply Chain Security Act;
7 49. “County jail” means a facility operated by a county for
8 the physical detention and correction of persons charged with, or
9 convicted of, criminal offenses or ordinance violations or persons
10 found guilty of civil or criminal contempt;
11 50. “State correctional facility” means a facility or
12 institution that houses a prisoner population under the
13 jurisdiction of the Department of Corrections;
14 51. “Unit dose package” means a package that contains a single
15 dose drug with the name, strength, control number, and expiration
16 date of that drug on the label; and
17 52. “Unit of issue package” means a package that provides
18 multiple doses of the same drug, but each drug is individually
19 separated and includes the name, lot number, and expiration date.
20
(Floor Amendments Only) Date and Time Filed:
Untimely Amendment Cycle Extended Secondary Amendment

[DELETED:  D        A  SS D N      S_S]
[DELETED:  D        A  S S a S S 1 m t p 2 3 w t 4 a t p a 5 6 r l m a]
[DELETED:  D        A  S l s 7 c c 8 d o p d p 9 p a d t 1 “ a f 3 b i f r o]
[DELETED:  D        A  S 1 o 1 e i p l D o 1 g d a t c d d u 1 t d p 3]
[DELETED:  D        A  S S p 1 t “ s S 1 o l e d 1 r N p d h f o 1 u n d]
[DELETED:  D        A  S 1 p 2 m i 2 t o 2 a a b a c a d a e a f a g a l w 2 r a a U U]
[DELETED:  D        A  S p o b a s p s c a o d o d a p 2 p a o b t p “ p f p]
[DELETED:  D        A  S 2 s s l 2 b 2 d d a p 2 m 2 h m 3 s t s S b t]
[DELETED:  D        A  S r U 3 f t a i b h a c c 3 3 p i s s i t 3 l o 3 l p]
[DELETED:  D        A  S l t 3 B c w p 3 m B n i s 3 t m w 3 a t o b t l m]
[DELETED:  D        A  S n l c t u d t t e t p o h f t o o g t n 3 c t 4 a p 4 m m]
[DELETED:  D        A  S a b b ( u p l ( b p c b a 4 f m b c a 4 p r w 4 p a s 4 c]
[DELETED:  D        A  S M t S p A d a b s p o 4 s w 3 4 p c i d o d “ d]
[DELETED:  D        A  S 4 d m p d S 4 t c f 5 i j 5 d d 5 m s ]